Cited by 275Influenza Virus Research StudiesPneumonia and Respiratory InfectionsRespiratory viral infections research

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index; none of the 12 sources its claims cite is checked for support yet.

Streptococcus pneumoniae Coinfection Is Correlated with the Severity of H1N1 Pandemic Influenza

Open access

Abstract

BACKGROUND: Initial reports in May 2009 of the novel influenza strain H1N1pdm estimated a case fatality rate (CFR) of 0.6%, similar to that of seasonal influenza. In July 2009, however, Argentina reported 3056 cases with 137 deaths, representing a CFR of 4.5%. Potential explanations for increased CFR included virus reassortment or genetic drift, or infection of a more vulnerable population. Virus genomic sequencing of 26 Argentinian samples representing both severe and mild disease indicated no evidence of reassortment, mutations associated with resistance to antiviral drugs, or genetic drift that might contribute to virulence. Furthermore, no evidence was found for increased frequency of risk factors for H1N1pdm disease. METHODS/PRINCIPAL FINDINGS: We examined nasopharyngeal swab samples (NPS) from 199 cases of H1N1pdm infection from Argentina with MassTag PCR, testing for 33 additional microbial agents. The study population consisted of 199 H1N1pdm-infected subjects sampled between 23 June and 4 July 2009. Thirty-nine had severe disease defined as death (n = 20) or hospitalization (n = 19); 160 had mild disease. At least one additional agent of potential pathogenic importance was identified in 152 samples (76%), including Streptococcus pneumoniae (n = 62); Haemophilus influenzae (n = 104); human respiratory syncytial virus A (n = 11) and B (n = 1); human rhinovirus A (n = 1) and B (n = 4); human coronaviruses 229E (n = 1) and OC43 (n = 2); Klebsiella pneumoniae (n = 2); Acinetobacter baumannii (n = 2); Serratia marcescens (n = 1); and Staphylococcus aureus (n = 35) and methicillin-resistant S. aureus (MRSA, n = 6). The presence of S. pneumoniae was strongly correlated with severe disease. S. pneumoniae was present in 56.4% of severe cases versus 25% of mild cases; more than one-third of H1N1pdm NPS with S. pneumoniae were from subjects with severe disease (22 of 62 S. pneumoniae-positive NPS, p = 0.0004). In subjects 6 to 55 years of age, the adjusted odds ratio (OR) of severe disease in the presence of S. pneumoniae was 125.5 (95% confidence interval [CI], 16.95, 928.72; p<0.0001). CONCLUSIONS/SIGNIFICANCE: The association of S. pneumoniae with morbidity and mortality is established in the current and previous influenza pandemics. However, this study is the first to demonstrate the prognostic significance of non-invasive antemortem diagnosis of S. pneumoniae infection and may provide insights into clinical management.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

In 199 Argentine H1N1pdm cases, *Streptococcus pneumoniae* coinfection was strongly associated with severe disease, especially in subjects aged 6–55 years (adjusted OR 125.5). The study suggests non-invasive antemortem detection of *S. pneumoniae* may have prognostic value for H1N1pdm severity.

Key findings

  • Among 199 H1N1pdm-positive nasopharyngeal swab samples, at least one additional potential pathogen was detected in 152 (76%); *S. pneumoniae* was found in 62 (35.5%).
  • *S. pneumoniae* was present in 56.4% of severe cases versus 25.0% of mild cases; 22 of 62 *S. pneumoniae*-positive samples were from severe cases (p = 0.0004). In subjects aged 6–55 years, the adjusted odds ratio for severe disease with *S. pneumoniae* was 125.5 (95% CI 16.95–928.72; p < 0.0001).
  • *H. influenzae* was common overall (104/199, 52.3%) but less frequent in severe disease (9/39, 23.1%) than mild disease (95/160, 59.4%; p < 0.0001). RSV A was more common in severe cases (6/39, 15.4%) than mild cases (5/160, 3.1%; p = 0.0085).
  • Of 45 subjects with bacterial respiratory pathogens other than *S. pneumoniae* or *H. influenzae*, 44 had mild disease (97.8%; p = 0.0004). Among 96 subjects receiving oseltamivir alone, 10 (10.4%) had severe disease, whereas 13 of 14 patients (92.9%) receiving antibiotics without antiviral medication had severe disease (p < 0.0001).

Methods

  • Nasopharyngeal swab samples from 199 H1N1pdm-infected subjects in Argentina, collected 23 June–4 July 2009; 39 had severe disease (death n = 20 or hospitalization n = 19) and 160 had mild disease.
  • H1N1pdm was confirmed by WHO-approved real-time PCR; samples were tested by MassTag PCR for 33 additional viral and bacterial respiratory pathogens.
  • Group comparisons used Mann-Whitney U and Fisher’s exact tests; multivariable logistic regression stratified by age risk category adjusted for RSV A, total number of agents detected, and presence of a medical risk factor.

Limitations

  • The paper states that information on passive tobacco smoke exposure, older siblings, and personal/familial atopic background was unavailable, and that underreporting of milder infections could not be excluded as an explanation for Argentina’s elevated case fatality rate.
  • Evident from the text: the observational design cannot establish causality, and severe and mild samples were randomly selected from different repositories (1769 severe cases vs. 1282 mild cases), which may introduce selection or confounding.
  • Evident from the text: missing data for age (181/199), sex (184/199), and antimicrobial use (120/199), plus the very wide adjusted OR confidence interval (16.95–928.72), suggest limited precision and possible sparse-data instability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0008540

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 12 cited sources checked · 0 supported · 0 flagged

Show all 21 claims

  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 7
  • The quote only partly states this claim. 1
21 of 21
  • The paper relies on this without support.

    Detection of S. pneumoniae in NPS indicates a clinically relevant infection rather than incidental colonization.

    “In our study of Argentinean victims of H1N1pdm, the presence of S. pneumoniae in NPS predicts severe disease outcome.”
    “First, S. pneumoniae is important in the pathogenesis and prognosis of H1N1pdm-associated disease.”
  • The paper relies on this without support.

    The association between S. pneumoniae and severe H1N1pdm disease is not confounded by antimicrobial treatment.

    “Risk of severe disease was diminished in subjects who received only oseltamivir. Of 96 subjects receiving oseltamavir alone, 10 (10.4%) had severe disease. In contrast, 13 of 14 patients (92.9%) who received antibiotics without antiviral medication had severe disease (p<0.0001).”
  • The paper relies on this without support.

    The 90.97% prediction accuracy of the logistic regression model is not due to overfitting.

    “Indeed, severity of disease in this low risk group can be predicted with 90.97% accuracy via a multivariable logistic regression model that considers the presence of S. pneumoniae together with viruses other than influenza and a risk-associated medical condition.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

  • Incorrect overall percentage for S. pneumoniae

    Minor

    Table 2 reports 62 S. pneumoniae-positive subjects among 199 subjects as 35.5%. The overall percentage is 31.2%; 35.5% instead matches the proportion of S. pneumoniae-positive subjects who had severe disease (22 of 62).

    Reported 35.5 · recomputed 31.155779

1 of 1

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

See all 275

Metadata

Authors
Palacios, G., Hornig, M., Cisterna, D., Savji, N., Bussetti, A. V., Kapoor, V., Hui, J., Tokarz, R., Briese, T., Baumeister, E., & Lipkin, W. I.
Affiliations
  • Columbia University (US)
  • Administración Nacional de Laboratorios e Institutos de Salud (AR)
Corresponding author
  • Palacios, Gustavo
  • Lipkin, W. Ian
Venue
PLoS ONE
Published
2009-12-31
Volume
4
Issue
12
Pages
e8540
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2098792130
Cited by
275
References
14
Citations by year
2026: 2 · 2025: 4 · 2024: 5 · 2023: 9 · 2022: 14 · 2021: 16 · 2020: 16 · 2019: 9 · 2018: 12 · 2017: 11 · 2016: 10 · 2015: 19 · 2014: 17 · 2013: 37 · 2012: 32
FWCI
21.13
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
  • Americanae (AECID Library) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Greater South Information System
  • Columbia Academic Commons (Columbia University)
Funders
  • U.S. Department of Defense
  • National Institutes of Health (n01ai30027-9-0-2, AI57158)
  • National Institute of Allergy and Infectious Diseases (U54 AI 57158, R01AI051292, R01 AI30027, AI051292, U54AI057158, N01 AI030027)
Topics
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords
Streptococcus pneumoniae, co-infection, H1N1 pandemic influenza, 2009 H1N1 influenza, disease severity, case fatality rate, Haemophilus influenzae, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, respiratory pathogens, Argentina, viral coinfection, bacterial co-infection
MeSH terms
Adolescent, Adult, Argentina, Child, Disease Outbreaks, Female, Humans, Influenza, Human, Male, Middle Aged, Pneumococcal Infections, Risk Factors, Bodily Secretions, Streptococcus pneumoniae, Polymerase Chain Reaction, Influenza A Virus, H1N1 Subtype, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review